Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:209-215
Published online before print January 17, 2005, doi: 10.1161/01.HYP.0000154085.27868.93
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/2/209    most recent
01.HYP.0000154085.27868.93v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petnehazy, T.
Right arrow Articles by Granger, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petnehazy, T.
Right arrow Articles by Granger, D. N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cholesterol
*Vasculitis
Hazardous Substances DB
*LOSARTAN POTASSIUM
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Aggregation
Right arrow Other Vascular biology

(Hypertension. 2005;45:209.)
© 2005 American Heart Association, Inc.


Scientific Contributions

Angiotensin II Type-1 Receptor Antagonism Attenuates the Inflammatory and Thrombogenic Responses to Hypercholesterolemia in Venules

Thomas Petnehazy; Karen Y. Stokes; Janice M. Russell; D. Neil Granger

From the Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport (K.Y.S., J.M.R., D.N.G.); and University Klinik for Pediatric Surgery (T.P.), University of Graz, Austria.

Correspondence to D. Neil Granger, PhD, Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, 1501 E Kings Highway, Shreveport, LA 71130-3932. E-mail dgrang{at}lsuhsc.edu

Hypercholesterolemia elicits an inflammatory response in the microvasculature that is accompanied by an increased expression of angiotensin II type-1 receptors (AT1-R) on platelets, leukocytes, and endothelial cells. AT1-R blockade attenuates inflammatory responses to angiotensin II (eg, adhesion molecule expression and reactive oxygen species production). We investigated whether AT1-R antagonism attenuates the platelet and leukocyte recruitment induced by acute hypercholesterolemia in postcapillary venules. Leukocyte and platelet adhesion and oxidative stress were quantified by intravital microscopy in cremaster muscle, and P-selectin and AT1-R expression was determined in mice placed on a normal diet (ND) or high-cholesterol diet (HCD) for 2 weeks. Platelet and leukocyte adhesion was significantly elevated by hypercholesterolemia. In HCD mice receiving losartan (HCD-Los) in drinking water, platelet and leukocyte recruitment was reduced to ND levels. Increased platelet adhesion was observed in HCD mice receiving platelets from HCD-Los mice, consistent with a direct beneficial action of losartan on the vessel wall. Hypercholesterolemia elicited an oxidative stress in venules and an increased expression of P-selectin and AT1-R. The oxidative stress and AT1-R upregulation were reduced by losartan, but the P-selectin response was not. We propose that AT1-R engagement contributes to the prothrombogenic and proinflammatory state induced in venules by hypercholesterolemia.


Key Words: receptors, angiotensin II • microcirculation • hypercholesterolemia • leukocytes




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Abu-Taha, C. Rius, C. Hermenegildo, I. Noguera, J.-M. Cerda-Nicolas, A. C. Issekutz, P. J. Jose, J. Cortijo, E. J. Morcillo, and M.-J. Sanz
Menopause and Ovariectomy Cause a Low Grade of Systemic Inflammation that May Be Prevented by Chronic Treatment with Low Doses of Estrogen or Losartan
J. Immunol., July 15, 2009; 183(2): 1393 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Chen, A. Pearlman, Z. Luo, and C. S. Wilcox
Hydrogen peroxide mediates a transient vasorelaxation with tempol during oxidative stress
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2085 - H2092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Ishikawa, E. Sekizuka, N. Yamaguchi, H. Nakadate, S. Terao, D. N. Granger, and H. Minamitani
Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2306 - H2315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Petnehazy, D. Cooper, K. Y. Stokes, J. Russell, K. C. Wood, and D. N. Granger
Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1203 - G1210.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. W. Alexander
Leukocyte and Endothelial Angiotensin II Type 1 Receptors and Microvascular Thrombotic and Inflammatory Responses to Hypercholesterolemia
Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 240 - 241.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Petnehazy, K. Y. Stokes, K. C. Wood, J. Russell, and D. N. Granger
Role of Blood Cell-Associated AT1 Receptors in the Microvascular Responses to Hypercholesterolemia
Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Vowinkel, K. C. Wood, K. Y. Stokes, J. Russell, C. F. Krieglstein, and D. N. Granger
Differential expression and regulation of murine CD40 in regional vascular beds
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H631 - H639.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Morawietz
Beyond Blood Pressure: Endothelial Protection Against Hypercholesterolemia by Angiotensin II Type-1 Receptor Blockade
Hypertension, February 1, 2005; 45(2): 185 - 186.
[Full Text] [PDF]